Abstract:CD4+ T cells are key players in immune-mediated inflammatory diseases (IMIDs) through the production of inflammatory mediators including tumour necrosis factor (TNF). Anti-TNF therapy has revolutionized the treatment of several IMIDs and we previously demonstrated that in vitro treatment of human CD4+ T cells with anti-TNF promotes anti-inflammatory IL-10 expression in multiple subpopulations of CD4+ T cells. Here we investigated the transcriptional mechanisms underlying the IL-10 induction by TNF-blockade in CD4+ T cells, isolated from PBMCs of healthy volunteers, stimulated in vitro for 3 days with anti-CD3/CD28 mAb in the absence or presence of anti-TNF. After culture, CD45RA+ cells were depleted before performing gene expression profiling and chromatin accessibility analysis. Gene expression analysis of CD45RA-CD4+ T cells showed a distinct anti-TNF specific gene signature of 183 genes (q-value < 0.05). Pathway enrichment analysis of differentially expressed genes revealed multiple pathways related to cytokine signalling and regulation of cytokine production; in particular, IL10 was the most upregulated gene by anti-TNF, while the proinflammatory cytokines and chemokines IFNG, IL9, IL22, and CXCL10 were significantly downregulated (q-value < 0.05). Transcription factor motif analysis at the differentially open chromatin regions, after anti-TNF treatment, revealed 58 transcription factor motifs enriched at the IL10 locus. We identified seven transcription factor candidates for the anti-TNF mediated regulation of IL-10, which were either differentially expressed or whose locus was differentially accessible upon anti-TNF treatment. Correlation analysis between the expression of these transcription factors and IL10 suggests a role for MAF, PRDM1, and/or EOMES in regulating IL10 expression in CD4+ T cells upon anti-TNF treatment.

Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10

IL-10 Targets IRFs to Suppress IFN and Inflammatory Response Genes by Epigenetic Mechanisms

Reprogramming of IL-10 Activity and Signaling by IFN-γ

Interleukin-10 Family Cytokines Immunobiology and Structure.

Reprogramming of IL-10 activity and signaling by IFN-gamma(1)

Interleukin-10 induces interferon-γ-dependent emergency myelopoiesis

Structures of the interleukin 11 signalling complex reveal gp130 dynamics and the inhibitory mechanism of a cytokine variant

Optimization of in Vitro Immunization Protocol to Produce Antigen Specific Human Monoclonal Antibody by Demonstrating the Role of IL-10

Genomic Analysis of LPS-stimulated Myeloid Cells Identifies a Common Pro-Inflammatory Response but Divergent IL-10 Anti-Inflammatory Responses

Identification of a transcription factor network regulating anti-TNF mediated IL10 expression in human CD4+ T cells

The regulation of IL-10 production by immune cells

Interleukin-10 Reorganizes The Cytoskeleton Of Mature Dendritic Cells Leading To Their Impaired Biophysical Properties And Motilities

IL-10 Has A Distinct Immunoregulatory Effect on Naive and Active T Cell Subsets

An IL-27-Driven Transcriptional Network Identifies Regulators of IL-10 Expression across T Helper Cell Subsets

Regulation of IL-10 expression and function by JAK-STAT in CD8 + T cells

Epigenetic Changes Associated With Interleukin-10

Structural Insights into IL-6 Signaling Inhibition by Therapeutic Antibodies

IL-10 constrains sphingolipid metabolism to limit inflammation

IL-10 downregulates CXCR3 expression on Th1 cells and interferes with their migration to intestinal inflammatory sites

Interleukin-10 and articular cartilage: experimental therapeutical approaches in cartilage disorders.

IL-10 engages macrophages to shift Th17 cytokine dependency and pathogenicity during T-cell-mediated colitis